
Bevacizumab combined with pemetrexed plus cisplatin followed by maintenance bevacizumab/pemetrexed as first-line treatment of advanced non-squamous non-small cell lung cancer: A single-arm Phase 2 study
Keywords: سیس پلاتین; NSCLC; Maintenance therapy; Pemetrexed; Cisplatin; Bevacizumab; Clinical trial;